Clinical Trial Update: Modified Process Hepatitis B Vaccine in Japanese Young Adults (V232-062) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update reports results for a modified process Hepatitis B vaccine in Japanese young adults; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Modified Process Hepatitis B Vaccine (V232-062)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis B | Phase 3 | Status: COMPLETED | Results posted: 2014-02-17